UroGen Pharma Ltd.

Ownership Transactions Reported by 15 Insiders

Symbol
URGN on Nasdaq
Location
9 Ha'ta'asiya St, Ra'anana, Israel

Insiders trading volume in the past year

UroGen Pharma Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ran Nussbaum Director $26.7 M Oct 21, 2022
Arie Belldegrun Director $7.36 M Sep 7, 2023
Elizabeth Barrett Chief Executive Officer $5.88 M Jan 31, 2024
Mark Schoenberg Chief Medical Officer $1.89 M -$355 K -15.8% Jun 10, 2024
Fred E. Cohen Director $1.25 M Sep 7, 2023
Dong Kim Chief Financial Officer $556 K Jan 31, 2024
Jason D. Smith General Counsel $369 K -$226 K -37.9% Jan 31, 2024
Molly Henderson Chief Financial Officer $94.5 K Jan 31, 2022
Daniel George Wildman Director Sep 7, 2023
Kathryn E. Falberg Director Jun 7, 2021
Cynthia M. Butitta Director Sep 7, 2023
James Robinson Director Sep 7, 2023
Shawn Tomasello Director Jun 7, 2021
Stuart Holden Director Sep 7, 2023
Leana Wen Director Sep 7, 2023

Recent Insider Transactions by Companies or Individuals for UroGen Pharma Ltd.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership